** Shares of medical equipment maker West Pharmaceuticals WST.N rise 1.3% to $221 premarket
** Company raised its annual profit forecast to $6.15 to $6.35 a share, up from a previous range of $6 to $6.20 a share
** This profit raise comes despite the company anticipating a $20 million to $25 million hit from U.S. President Donald Trump's tariffs
** Analysts on average were expecting annual profit of $6.14/share, as per data compiled by LSEG
** WST posts Q1 revenue of $698 million, beating Wall Street estimate of $685.84 million
** Co reports Q1 adj. profit of $1.45/share, vs analysts' estimate of $1.23/share
** As of last close, WST stock down 33.4% YTD
(Reporting by Padmanabhan Ananthan)
((Padmanabhan.Ananthan@thomsonreuters.com))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。